USA researchers identify potential biomarkers for detection and treatment of triple-negative breast cancer

“The broader vision and mission of our study is to develop a minimally invasive blood test kit for early diagnostics, monitoring, and guiding therapeutic planning of triple-negative breast cancer patients.”

Breast cancer biomarkers, and a new clinical category for HER2

Seema Singh, Ph.D.

Recent advances in targeted strategies for triple-negative breast

Breast Cancer Research Foundation of Alabama on LinkedIn: Welcome, Kate Lloyd, to the BCRFA board of directors! ✨ Kate is a breast…

Triple Negative Breast Cancer Market Size & Share Trends: 2032

Breast Cancer Research Foundation of Alabama on LinkedIn: Welcome, Kate Lloyd, to the BCRFA board of directors! ✨ Kate is a breast…

Seema Singh, Ph.D.

Relevant breast cancer biomarkers at different time points in

Triple-Negative Breast Cancer: Biomarkers, Emerging Therapeutic

Diagnostics, Free Full-Text